How Techcyte’s Fusion Platform is Shaping the Future of Digital Pathology and AI Integration
At USCAP 2025, Techcyte’s Chief Medical Officer, Dr. Tiffany Chen, and CEO, Ben Cahoon, joined Dr. Aleks Zuraw of Digital Pathology Place to celebrate the launch of Fusion AP. They discussed how Fusion streamlines case management, enhances diagnostic accuracy, and integrates AI into everyday pathology workflows. The conversation also covered the importance of open standards, Techcyte’s partnerships, and the critical role of flexible integration in driving healthcare innovation.
On our website we use cookies to enhance your experience, and for analytics purposes. To learn more about our cookies, please read our Cookies Policy. By clicking “Accept Cookies”, you agree to our use of cookies. By clicking “Decline”, you don’t agree to our Privacy Policy.